IQSI - ETF AI Analysis
Top Page
IQ Candriam ESG International Equity ETF (IQSI)
Rating:67Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries, led by Japan, the UK, Australia, and several European markets, help reduce the impact of weakness in any single region.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Negative Factors
Mixed Top Holding Performance
While some major positions like ASML and Schneider Electric have performed strongly, others such as SAP, Nestlé, and Roche have been weak, which can drag on overall returns.
Heavy Exposure to Japan
A large allocation to Japanese stocks means the fund is especially sensitive to economic and market conditions in Japan.
Concentrated in a Few Key Sectors
Significant weight in general, financial, and health care sectors increases the fund’s vulnerability if these areas fall out of favor.
IQSI vs. SPDR S&P 500 ETF (SPY)
AUM233.94M
RegionDeveloped Markets
Expense Ratio0.15%
Beta0.76
IssuerNew York Life Investments
Inception DateDec 17, 2019
Dividend Yield2.57%
Asset ClassEquity
Index TrackedIQ Candriam ESG International Equity Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,366
30 Day Avg. Volume13,023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
42.71Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering596
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IQSI Summary
IQ Candriam ESG International Equity ETF (IQSI) tracks the IQ Candriam ESG International Equity Index, investing in a wide mix of companies outside the U.S. that meet environmental, social, and governance (ESG) standards. It holds well-known names like Toyota, Nestlé, ASML, and AstraZeneca across many countries and sectors, giving investors broad global diversification while aligning with sustainable business practices. Someone might invest in IQSI to spread their money across many international stocks and support companies with stronger ESG profiles. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The IQ Candriam ESG International Equity ETF (IQSI) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.
What would affect this ETF?The IQ Candriam ESG International Equity ETF could benefit from growing global interest in ESG investing, as more individuals and institutions prioritize sustainability and ethical practices. However, its exposure to developed markets and sectors like Financials and Industrials may face challenges if economic growth slows or interest rates rise, which could impact corporate profitability. Additionally, regulatory changes or geopolitical tensions in key regions could create uncertainty for some of its top holdings.
IQSI Top 10 Holdings
IQSI’s story is driven by a handful of European heavyweights. ASML has been rising and looks like the fund’s main engine, while Schneider Electric and Siemens are also adding welcome spark from the industrial side. Health care names are more of a mixed bag: AstraZeneca and Novartis are steady helpers, but Roche is lagging and taking some shine off the sector. SAP has been notably weak, acting as a drag. Overall, the ETF leans toward developed international markets, especially Europe, with no single stock overpowering the mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.11% | $9.64M | €477.33B | 106.32% | 76 Outperform | |
| AstraZeneca | 2.09% | $4.89M | $292.69B | 32.74% | 80 Outperform | |
| Roche Holding AG | 2.05% | $4.81M | $327.04B | 22.13% | 73 Outperform | |
| Novartis AG | 1.98% | $4.65M | CHF207.57B | 22.14% | 80 Outperform | |
| Nestlé SA | 1.90% | $4.45M | CHF205.30B | -1.29% | 71 Outperform | |
| Siemens | 1.64% | $3.84M | €185.31B | 21.53% | 74 Outperform | |
| Commonwealth Bank of Australia | 1.52% | $3.57M | AU$291.71B | 6.28% | 64 Neutral | |
| Toyota Motor | 1.45% | $3.39M | ¥39.97T | 10.07% | 80 Outperform | |
| Schneider Electric | 1.30% | $3.04M | €155.45B | 27.66% | 62 Neutral | |
| SAP SE | 1.28% | $2.99M | €171.96B | -40.47% | 66 Neutral |
IQSI Technical Analysis
Positive
―
Price Trends
36.59
Positive
36.32
Positive
34.95
Positive
Market Momentum
0.22
Positive
55.87
Neutral
26.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.04, equal to the 50-day MA of 36.59, and equal to the 200-day MA of 34.95, indicating a bullish trend. The MACD of 0.22 indicates Positive momentum. The RSI at 55.87 is Neutral, neither overbought nor oversold. The STOCH value of 26.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQSI.
IQSI Peer Comparison
Comparison Results
Performance Comparison
IQSI
IQ Candriam ESG International Equity ETF
37.35
6.13
19.63%
URTH
iShares MSCI World ETF
―
―
―
GSWO
Goldman Sachs ActiveBeta World Equity ETF
―
―
―
WSML
iShares MSCI World Small-Cap ETF
―
―
―
GDIV
Harbor Dividend Growth Leaders ETF
―
―
―
QWLD
SPDR MSCI World StrategicFactors ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents